The Siperka is independent, hardy, and built for harsh conditions. But beneath that thick coat lurk breed-specific health issues - hip problems, eye conditions, and autoimmune diseases require serious financial planning.
Measured risks
How often they happen is backed by published studies.
What is this?Hide
All dogs [1] General canine population rate (Lund et al. 1999), not Schipperke-specific.
Periodontal disease affects over 80% of dogs by age 3. Bacteria from infected teeth enter the bloodstream, damaging heart, kidneys, and liver over time. Full profile →
What is this?Hide
Confirmed [2] 1.5% of over 3,200 Schipperkes genotyped between 2003-2019 were homozygous (affected) for the causative NAGLU gene insertion (Abitbol et al. 2020, Scientific Reports). OFA CHIC requires this DNA test for the breed's health certification.
A fatal inherited storage disease unique to this breed. Affected dogs develop tremors and loss of coordination around age 2-4 and are usually euthanized within a few years.
Known risks
Well documented in the breed - but no study has counted how often.
What is this?Hide
Breed study Schipperkes are reported to have higher than average patellar luxation risk among small breeds (breed health sources, OFA CHIC lists patella exam as a required test), but no population prevalence percentage was found.
The kneecap slips out of its groove, causing skipping or limping gaits. Common in small breeds; severe cases need surgery. Full profile →
What is this?Hide
Breed study Higher incidence of Legg-Calve-Perthes has been noted in Schipperkes among small-breed dogs (OFA); OFA CHIC recommends hip x-rays for this condition. No population prevalence percentage was found.
Loss of blood supply to the head of the femur in young dogs, usually appearing between 6-9 months as hind-limb lameness. Surgery is typically curative. Full profile →
What is this?Hide
Not measured A full thyroid panel is part of OFA CHIC's minimum testing requirement for the breed, but no published prevalence data was found.
Underactive thyroid causing weight gain, lethargy, and coat problems. Full profile →
What is this?Hide
Not measured No Schipperke-specific allergy prevalence data was found.
Chronic skin inflammation causing persistent itching and repeated infections. Full profile →
How we know these numbers
- Confirmed = measured or gene-confirmed specifically in this breed
- Breed study = scientists counted it in this exact breed
- Body type = comes from the dog's build - size, skull, skin
- Genetic risk = the gene is proven, the odds are not
- All dogs = an average for all dogs, not this breed
- Not measured = nobody has counted it yet
- How we grade evidence →
Most owners sign a policy based on ads, but learn the real rules only when their first big claim gets denied. We don't want to scare you. We want to prepare you.
Price Explosion Premium creep
Hostage Status Pre-existing
The Year 6 Rule Age limit
Symptom = Game Over Pre-existing
Bilateral Exclusion Bilateral
AI Claims Adjuster Coverage
Orthopedic Waiting Period Waiting period
UCR Limits Exclusion
Common Questions
Real answers about costs, treatment, and insurance coverage.
What is the most common health problem in Siperkas?
How much does pet insurance cost for a Siperka?
Is pet insurance worth it for a Siperka?
What is the average yearly vet cost for a Siperka?
What pre-existing conditions affect Siperka insurance coverage?
Does pet insurance cover Legg-Calve-Perthes disease in Siperkas?
What is Mucopolysaccharidosis IIIB (MPS IIIB) and how much does testing cost for a Siperka?
Why does my Siperka insurance premium keep going up every year?
Can I switch pet insurance if my Siperka has a diagnosed condition?
What does pet insurance not cover for Siperkas?
Should I get pet insurance or self-insure my Siperka?
What questions should I ask before insuring my Siperka?
Similar dogs
My mother-in-law's boxer. Problem. $1,200 in tests, no answers. Another vet solved it with $8 pills. When you're scared, you'll pay anything - and some vets price accordingly. So I built what I couldn't find: real costs, real exclusions, plain language. Not selling policies.
Sources
Research and data used to compile this profile.
- 1 Lund EM, Armstrong PJ, Kirk CA, Kolar LM, Klausner JS. Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States. J Am Vet Med Assoc. 1999;214(9):1336-41.
- 2 Abitbol M, et al. An exonic insertion in the NAGLU gene causing Mucopolysaccharidosis IIIB in Schipperke dogs. Scientific Reports. 2020;10:1465.
- 3 OFA - Legg-Calve-Perthes disease overview and breed screening recommendations.